Pharma Journalist - Page 67 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Honoring Excellence: The 10th Annual Microbiome Movement Awards

Moderna’s mNEXSPIKE COVID-19 Vaccine Wins FDA Approval

ImmunityBio Gets FDA Expanded Access for ANKTIVA in Solid Tumors

Sanofi to Acquire Blueprint Medicines, Boosting Rare Disease and Immunology Pipeline

Itepekimab Hits Primary Goal in One of Two COPD Phase 3 Trials

CirCode Biomed Gets FDA Clearance for First Circular RNA Drug HM2002

BioNTech, BMS Launch Global Partnership to Develop Cancer Therapy BNT327

Astellas Licenses XNW27011 ADC from Evopoint Biosciences

Teva’s Celiac Disease Drug Receives FDA Fast Track Designation

Biogen and City Therapeutics Launch Collaboration to Develop RNAi-Based Therapies